Back to top
more

Eventide Healthcare & Life Sciences Fd Cl A: (MF: ETAHX)

(NASDAQ Mutual Funds) As of Dec 18, 2025 05:22 PM ET

$49.02 USD

-0.49 (-0.99%)

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

2-Buy of 5   2      

View All Zacks Mutual Fund Rank #1's

Latest Performance as of Nov 30, 2025

Total Return %* Percentile Rank Objective
YTD 59.32 1
3 months 34.71 6
6 months 68.08 3
1 Year 44.14 4
3 Year 18.36 9
5 Year 1.96 94
10 Year 10.36 5

* Annual for three years and beyond.

Zacks Premium Research for ETAHX

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Buy 2
MF Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

% Unrealized Gain 14.42
% Yield 0.00
% SEC Yield NA
Net Assets (Mil $) 11/30/2025 144.66
% Turnover 11/30/2025 41.00

Risk

3 Year 5 Year 10 Year
Beta 0.93 0.72 1.01
Alpha 1.33 -6.71 -1.14
R Squared 0.23 0.19 0.30
Std. Dev. 24.30 24.63 27.79
Sharpe 0.67 0.08 3.00

Sector / Country Weightings

As of 11/30/2025 % of Portfolio
Health 76.49
Other 11.99
Services 10.54
Technology 0.98

Portfolio Holdings

Top Equity Holdings
(As of 6/30/2025)
% of Portfolio Value (Mil$)
INSMED INC 6.76 77.48
VERONA PHARMA PLC 6.68 76.53
MIRUM PHARMACEUTICALS INC 5.31 60.79
GUARDANT HEALTH INC 4.94 56.63
SCHOLAR ROCK HOLDING CORP 4.45 50.99
ALNYLAM PHARMACEUTICALS I 3.56 40.75
TOTAL*OTHER EQUITIES 3.44 39.38
BLUEPRINT MEDICINES CORPO 3.35 38.43
AXSOME THERAPEUTICS INC 3.34 38.28

Stock Holding % of Net Assets

As Of 6/30/2025
Total Issues 44
Avg. P/E NA
Avg. P/Book 5.39
Avg. EPS Growth NA
Avg. Market Value (Mil $) 7,970

Composition

% of Portfolio
Stocks 97.04
Foreign Stocks 2.37
Cash 0.31
Bonds 0.00
Foreign Bonds 0.00
Preferred 0.00
Convertible 0.02
Other 2.63
Foreign Hedged 0.00

Style Analysis

% of Portfolio
Large Growth 0.00
Large Value 0.00
Small Growth 14.38
Small Value 0.00
Foreign Stock 0.99
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 10.93
Foreign Bond 0.00
High Yield Bond 0.00